Do antiepileptic drugs cause premature atherosclerosis by disturbing lipid metabolism?

Basit Öğe Kaydı
dc.authoridTUNA, GAMZE/0000-0002-7311-4020
dc.authoridEskut, Neslıhan/0000-0003-1882-8992
dc.authorwosidTUNA, GAMZE/Q-1951-2019
dc.authorwosidEskut, Neslıhan/O-1600-2013
dc.contributor.authorEskut, Neslihan
dc.contributor.authorSoysuren, Cagla
dc.contributor.authorDogan, Gulec Mert
dc.contributor.authorTuna, Gamze
dc.contributor.authorToksoz, Feriha
dc.contributor.authorCalis, Nazif
dc.contributor.authorCetiner, Mustafa
dc.date.accessioned2024-08-04T20:57:42Z
dc.date.available2024-08-04T20:57:42Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: The aim of this study was to evaluate susceptibility to atherosclerosis in epileptic patients on carbamazepine and valproic acid monotherapy with lipid profile, lipoprotein (a) (lp(a)), oxidized low-density lipoprotein (LDL), adiponectin, and carotid artery intima-media thickness measurements. Material and Methods: Of the 108 patients with epilepsy included in the study, 64 (36 female, 28 male) were receiving valproic acid monotherapy and 44 (25 female, 19 male) were receiving carbamazepine monotherapy. The control group comprised 48 (30 female, 18 male) healthy participants. Liver and kidney function tests, cholesterol, triglycerides, LDL, high-density lipoprotein (HDL), lp(a), oxidized LDL, adiponectin, and common carotid (CCA) and internal carotid artery (ICA) intima-media thickness (IMT) were investigated in both the patient and control groups. Results: Mean age was 32.34 +/- 12.41 years in the valproic acid group, 32.70 +/- 11.64 years in the carbamazepine group, and 35.81 +/- 11.76 years in the control group. Liver and kidney function test results were normal in all groups. Cholesterol levels were lower in the valproic acid group than the other groups. HDL levels were higher in the carbamazepine group than other groups. Adiponectin levels were lower in the valproic acid group. In all groups, cholesterol and LDL levels were higher in individuals older than 50 years old. When the patients were evaluated according to the duration of drug use, cholesterol and LDL levels were higher in patients who had used drugs for more than 5 years in the valproic acid group. There were no differences between the groups for triglyceride, oxidized LDL, or lp(a) levels or CCA and ICA IMT. Discussion: There are conflicting results in the literature regarding epilepsy and atherosclerosis associated with antiepileptic drug usage. In this study, no evidence was found of an increasing risk of arteriosclerosis associated with antiepileptic drugs by measuring lipids, lipoprotein, oxidized LDL, adiponectin levels, and CCA and ICA IMT. However, it is important to monitor lipid levels in the follow-up of patients with epilepsy, especially for patients requiring longterm antiepileptic therapy and also older patients.en_US
dc.identifier.doi10.4328/ACAM.20820
dc.identifier.endpage103en_US
dc.identifier.issn2667-663X
dc.identifier.issue1en_US
dc.identifier.startpage98en_US
dc.identifier.urihttps://doi.org/10.4328/ACAM.20820
dc.identifier.urihttps://hdl.handle.net/11616/102849
dc.identifier.volume13en_US
dc.identifier.wosWOS:000729248900001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherBayrakol Medical Publisheren_US
dc.relation.ispartofAnnals of Clinical and Analytical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEpilepsyen_US
dc.subjectAntiepileptic Drugen_US
dc.subjectAtherosclerosisen_US
dc.subjectLipoproteinen_US
dc.subjectCarotid Intima-Media Thicknessen_US
dc.titleDo antiepileptic drugs cause premature atherosclerosis by disturbing lipid metabolism?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu